Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
37.9M
-
Shares change
-
+733K
-
Total reported value, excl. options
-
$315M
-
Value change
-
+$6.4M
-
Put/Call ratio
-
0.08
-
Number of buys
-
67
-
Number of sells
-
-68
-
Price
-
$8.39
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q1 2025
165 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q1 2025.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.9M shares
of 63.2M outstanding shares and own 59.93% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (6.21M shares), BlackRock, Inc. (3.88M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (3.06M shares), VANGUARD GROUP INC (2.71M shares), CIBC Private Wealth Group LLC (2.29M shares), JPMORGAN CHASE & CO (1.85M shares), GAGNON SECURITIES LLC (1.75M shares), MORGAN STANLEY (1.53M shares), DEUTSCHE BANK AG\ (1.28M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.09M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.